- Opinion: $2 million gene therapy cures require a financing model“We do not lack cures. We lack the infrastructure to pay for and deliver them,” writes William Padula.STAT · 1mo ago↗ source
- STAT+: Competition for obesity drugs, clinical blind spots, and more news from ADAYou're reading the web edition of STAT's ADA in 30 Seconds, from the American Diabetes Association's annual conference.STAT · 1mo ago↗ source
- STAT+: New data may cast doubt on competitiveness of Boehringer’s obesity drugBoehringer Ingelheim’s obesity drug showed promise in cutting liver fat, but it was less impressive at overall weight loss, new data shows.STAT · 1mo ago↗ source